Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06673329
What this trial is testing

Brodalumab in the Treatment of Immune-Related Adverse Events

Who this might be right for
Breast CancerEsophageal CancerKidney Cancer+15 more
Brian Henick, MD 11
Not applicableActive Not RecruitingNCT02044172
What this trial is testing

Prostate Testing for Cancer and Treatment

Who this might be right for
Prostate Cancer
University of Oxford 82,849
Testing effectiveness (Phase 2)Study completedNCT00003312
What this trial is testing

Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 95
Not applicableStudy completedNCT00292019
What this trial is testing

Robotic Laparoscopic Radical Prostatectomy

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Testing effectiveness (Phase 2)Study completedNCT01942837
What this trial is testing

Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 67
Early research (Phase 1)Ended earlyNCT03436745
What this trial is testing

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 12
Not applicableWithdrawnNCT02905201
What this trial is testing

A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Large-scale testing (Phase 3)Ended earlyNCT00236002
What this trial is testing

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Who this might be right for
Osteoporosis
Canadian Urology Research Consortium 182
Not applicableLooking for participantsNCT04172753
What this trial is testing

Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

Who this might be right for
Rectal CancerHead and Neck CancerLiver Cancer+4 more
University Hospital Tuebingen 472
Large-scale testing (Phase 3)Study completedNCT00247312
What this trial is testing

Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial

Who this might be right for
Prostatic Neoplasm
Schiffler Cancer Center 319
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Not applicableLooking for participantsNCT05478694
What this trial is testing

Outcomes of Focal Ablation for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 225
Testing effectiveness (Phase 2)Study completedNCT00150995
What this trial is testing

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 19
Large-scale testing (Phase 3)Study completedNCT03009981
What this trial is testing

Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance Foundation Trials, LLC. 504
Not applicableUnknownNCT03979339
What this trial is testing

Feasibility of a New Technology for Isolating Circulating Tumour Cells

Who this might be right for
HER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more
Centre Oscar Lambret 76
Not applicableActive Not RecruitingNCT03857477
What this trial is testing

The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 4,700
Not applicableLooking for participantsNCT07614256
What this trial is testing

Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction

Who this might be right for
Prostate Cancer (Diagnosis)Clinically Significant Prostate Cancer
Guangxi Medical University 3,000
Testing effectiveness (Phase 2)Ended earlyNCT02913131
What this trial is testing

Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Prostate Cancer
Rahul Aggarwal 23
Testing effectiveness (Phase 2)Ended earlyNCT05075577
What this trial is testing

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Who this might be right for
Prostate Cancer
ESSA Pharmaceuticals 77
Next Page